Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kris C. Sekar"'
Autor:
Peter Johnson, Kaitlin M. Hughes, Jamie L. Miller, Stephen Neely, Kris C. Sekar, Amy L. Nguyen, Robert C. Welliver
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVES The primary objective was to compare the volume of distribution (Vd), clearance (CL), elimination rate (Ke), and half-life (t½) of amikacin in neonates with cyanotic defects, acyanotic defects, and controls, adjusted for gestational and p
Autor:
Robert C. Welliver, Peter Johnson, Kris C. Sekar, Jamie L. Miller, Kaitlin M. Hughes, Michael P. Anderson
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 22:33-40
OBJECTIVES The primary aim was to compare attainment of goal serum amikacin concentrations using two dosage regimens in patients admitted to a neonatal intensive care unit. Secondary objectives included comparison of percentages of supratherapeutic t
Autor:
Susan Bedwell, Paul S. Tlucek, R. Michael Siatkowski, Karen E. Corff, Kris C. Sekar, Brianna C. Bright
Publikováno v:
Journal of American Association for Pediatric Ophthalmology and Strabismus. 14:406-411
The authors of previous studies suggest that the oxygenation status of premature infants contributes to the development of retinopathy of prematurity (ROP). In this study we compared the incidence and severity of ROP before and after institution of a
Autor:
Istvan Seri, Michael McCoy, Philippe Friedlich, Venugopal Gottipati, Brianna C. Bright, Kris C. Sekar, Shahab Noori
Publikováno v:
Pediatrics. 123:e138-e144
OBJECTIVE. Because the standard of care has been to attempt to close the patent ductus arteriosus in preterm neonates, there is a paucity of information on the outcome of patients with a persistent patent ductus arteriosus. Our objective was to compa
Autor:
Richard L. Auten, Thomas N. George, Vinod K. Bhutani, Dale R. Gerstmann, Steven H. Abman, Mark C. Mammel, Gary Cutter, Robert J. Couser, Carl L. Bose, Heather Carriedo, W. Michael Southgate, David C. Hall, Kris C. Sekar, William F. Walsh, Jeffrey S. Gerdes, Monika Baier, Mariann Pappagallo, Claudia Hart, Smeeta Sardesai, John Kinsella, John D. Strain
Publikováno v:
New England Journal of Medicine. 355:354-364
The safety and efficacy of early, low-dose, prolonged therapy with inhaled nitric oxide in premature newborns with respiratory failure are uncertain.We performed a multicenter, randomized trial involving 793 newborns who were 34 weeks of gestational
Autor:
Kris C. Sekar, Karen E. Corff
Publikováno v:
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 12(3)
When medical management is warranted for closure of a persistent patent ductus arteriosus (PDA) in premature infants, treatment with a cyclooxygenase (COX) inhibitor is indicated. Indomethacin, available since 1976, has been the conventional pharmaco
Autor:
Kris C, Sekar
Publikováno v:
Chinese medical journal. 123(22)
Autor:
Kris C, Sekar
Publikováno v:
Chinese medical journal. 123(20)
Autor:
Kris C. Sekar
Publikováno v:
Journal of perinatology : official journal of the California Perinatal Association. 26
Nitric oxide (NO) is a gas that has potent vasodilator properties. It can be administered via inhalation in situations where NO production is impaired and results in vasodilatation of the pulmonary capillaries. In term infants, the administration of
Autor:
Kris C. Sekar
The use of mechanical ventilation for the treatment of respiratory distress syndrome (RDS) in low birth weight infants may cause barotrauma, volutrauma, and chronic lung disease. Different continuous positive airway pressure (CPAP) delivery systems e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31340e98ef3c56a10f6bbc11f7037fe
https://europepmc.org/articles/PMC3468091/
https://europepmc.org/articles/PMC3468091/